1. Home
  2. GDYN vs VIR Comparison

GDYN vs VIR Comparison

Compare GDYN & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grid Dynamics Holdings Inc.

GDYN

Grid Dynamics Holdings Inc.

HOLD

Current Price

$9.27

Market Cap

727.6M

Sector

Technology

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$6.02

Market Cap

825.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDYN
VIR
Founded
2006
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
727.6M
825.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
GDYN
VIR
Price
$9.27
$6.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$11.25
$25.73
AVG Volume (30 Days)
943.5K
2.0M
Earning Date
10-30-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
457.52
N/A
EPS
0.16
N/A
Revenue
$405,955,000.00
$16,860,000.00
Revenue This Year
$19.77
N/A
Revenue Next Year
$10.24
$46.25
P/E Ratio
$56.87
N/A
Revenue Growth
23.63
N/A
52 Week Low
$7.37
$4.16
52 Week High
$25.50
$14.45

Technical Indicators

Market Signals
Indicator
GDYN
VIR
Relative Strength Index (RSI) 51.11 48.14
Support Level $9.07 $5.73
Resistance Level $9.95 $6.16
Average True Range (ATR) 0.37 0.36
MACD -0.08 -0.08
Stochastic Oscillator 16.23 22.93

Price Performance

Historical Comparison
GDYN
VIR

About GDYN Grid Dynamics Holdings Inc.

Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: